Frontlight ResearchEarly access
Trial site
Sichuan Cancer Hospital & Institute
- 11running trials
- 2closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Gastric and oesophageal cancer5 trials
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 27 trials
- Phase 33 trials
- Phase 2/31 trial
- Status
- Not yet recruiting5 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2 trials
- Astellas Pharma Global Development, Inc.1 trial
- Chengdu SciMount Pharmatech Co., Ltd.1 trial
- CStone Pharmaceuticals1 trial
- Jazz Pharmaceuticals1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Recruiting
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Recruiting
Active, not recruiting
Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer
Recruiting
Recruiting
Active, not recruiting
A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026